Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Operating Grant

University of Ottawa

$100,000.00

Role of GATA transcription factors in the heart

FY 2015-16

Summary
Congenital heart disease (CHD) affects 1-2% of the population and represents the largest class of birth defects. It is the leading cause of death in infants during the first year of life. It is also an independent risk factor for premature onset of adult cardiovascular disease including degenerative valve disease, myocardial infarction and sudden death. It is well established that CHD is a heritable trait, i.e. it 'runs in the family'. However, its transmission does not follow simple Mendelian inheritance and is influenced by other genetic as well as environmental factors. Despite great advances over the past decade, the causative genes responsible for the majority of human CHD remain unknown. A better understanding of the genes required for normal heart development will immensely advance our understanding, detection and care of CHD. During the past decade, our lab has proudly contributed to this thru our discovery and characterization of several genes essential for normal heart development such as GATA4 and GATA5. Alterations in these genes are associated with several types of human CHD, including bicuspid aortic valve, atrial and ventricular septal defects as well as rhythm abnormalities. Using our unique tools and animal models of human disease, we wish to pursue our studies aimed at understanding the essential role of these GATA proteins at various stages of heart development and in different cardiac cells. We also intend to use our animal models of CHD to elucidate the degenerative nature of CHD in the hope of preventing cardiac dysfunction and other cardiovascular complications such as valve deterioration and the need for valve replacement. The results of this study will continue to impact diagnosis and care of individuals with heart disease or with a family history of the disease.
Program
Operating Grant
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
332992
Name
Nemer Mona
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Circulatory and Respiratory Health
Theme2
Biomedical
Prcname2
Cardiovascular System - A: Cells and Tissues
Projecttitle
Role of GATA transcription factors in the heart
Programtype2
Operating Grants
Orgnameinp2
University of Ottawa
Cihramount2
$100,000
Cihrequipment2
$0
Programname2
Operating Grant
Keyworddelim
Congenital Heart Disease/Heart Failure; Molecular And Cell Biology; Protein Characterization; Transcription Factors/Heart Development; Transcription Regulation; Transcription/Signal Transduction; Transgenic Mice
Abstract
Congenital heart disease (CHD) affects 1-2% of the population and represents the largest class of birth defects. It is the leading cause of death in infants during the first year of life. It is also an independent risk factor for premature onset of adult cardiovascular disease including degenerative valve disease, myocardial infarction and sudden death. It is well established that CHD is a heritable trait, i.e. it 'runs in the family'. However, its transmission does not follow simple Mendelian inheritance and is influenced by other genetic as well as environmental factors. Despite great advances over the past decade, the causative genes responsible for the majority of human CHD remain unknown. A better understanding of the genes required for normal heart development will immensely advance our understanding, detection and care of CHD. During the past decade, our lab has proudly contributed to this thru our discovery and characterization of several genes essential for normal heart development such as GATA4 and GATA5. Alterations in these genes are associated with several types of human CHD, including bicuspid aortic valve, atrial and ventricular septal defects as well as rhythm abnormalities. Using our unique tools and animal models of human disease, we wish to pursue our studies aimed at understanding the essential role of these GATA proteins at various stages of heart development and in different cardiac cells. We also intend to use our animal models of CHD to elucidate the degenerative nature of CHD in the hope of preventing cardiac dysfunction and other cardiovascular complications such as valve deterioration and the need for valve replacement. The results of this study will continue to impact diagnosis and care of individuals with heart disease or with a family history of the disease.
Competitiondate
201505
Approvedterm2
1 yr 0 mth
Pinamesdelim
Nemer, Mona
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $100,000~ $0~
University of Ottawa - $100,000 Grant (2015-16) | Canada Spends